Abstract | BACKGROUND: OBJECTIVE: To compare the efficacy of a new skin lightening product with and without iontophoresis to a known effective product ( tretinoin) and placebo on hyperpigmentation caused by lentigines and/or melasma. Secondary objectives included an assessment of the product's effects on the appearance of rhytides and roughness. METHODS AND MATERIALS: Eighty subjects were randomized into one of four treatment groups: proprietary lightening product, proprietary lightening product with iontophoresis, tretinoin 0.05% cream, or vehicle control. Seventy-four subjects completed all study visits. Blinded assessments of subjects were performed at each visit under ambient and Wood's light. RESULTS: The proprietary skin lightening product improved facial hyperpigmentation versus placebo under ambient light (P= 0.05) and Wood's lamp (P= 0.01) examination. Tretinoin also improved facial hyperpigmentation versus placebo under Wood's lamp (P= 0.01). The proprietary product was better tolerated than tretinoin, with fewer subject reported side effects. CONCLUSION: The investigational product was effective and may be better tolerated than tretinoin cream.
|
Authors | Molly Wanner, Neil Houston, Emilia Javorsky, Minsheng Yuan, Maria Alora-Palli, Alexa B Kimball |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 14
Issue 1
Pg. 13-8
(Jan 2015)
ISSN: 1545-9616 [Print] United States |
PMID | 25607903
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Dermatologic Agents
- Skin Lightening Preparations
- Tretinoin
|
Topics |
- Adult
- Dermatologic Agents
(administration & dosage, adverse effects)
- Female
- Humans
- Hyperpigmentation
(drug therapy)
- Iontophoresis
(methods)
- Lentigo
(drug therapy)
- Melanosis
(drug therapy)
- Middle Aged
- Single-Blind Method
- Skin Aging
(drug effects)
- Skin Lightening Preparations
(administration & dosage, adverse effects)
- Treatment Outcome
- Tretinoin
(administration & dosage, adverse effects)
|